Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Suvorexant for Insomnia in Parkinson Disease
Conditions
Interventions
Suvorexant
Placebo
Locations
1
United States
Evergreenhealth Booth Gardner Parkinsons Care Center
Kirkland, Washington, United States
Start Date
April 1, 2016
Primary Completion Date
April 1, 2022
Completion Date
April 1, 2022
Last Updated
August 20, 2024
NCT06032377
NCT06181643
NCT06807086
NCT07429578
NCT05780814
NCT06348082
Lead Sponsor
Burdick, Daniel, M.D.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions